Clinical characteristics and outcomes for patients with non‑metastatic castration-resistant prostate cancer
Abstract This study used linked, routinely-collected datasets to explore incidence, clinical characteristics and outcomes of prostate cancer (PC) patients who experience a rise in prostate-specific antigen (PSA) levels despite androgen deprivation therapy (ADT), without evidence of metastases in the...
Enregistré dans:
Auteurs principaux: | Peter Arnold, Maria Cristina Penaloza-Ramos, Lola Adedokun, Sarah Rees, Mohamed Lockhat, Lisa Spary, Alan Watkins, Vincent Gnanapragasam, Simon J. Crabb |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/77469af6cc4b4e7585b202b8548a0ce0 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer
par: Nikolai A. Ognerubov
Publié: (2021) -
Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer
par: Jingsong Zhang, et autres
Publié: (2017) -
Advanced Therapeutic Options for Treatment of Metastatic Castration Resistant Prostatic Adenocarcinoma
par: Faiza Naseer, et autres
Publié: (2021) -
Metastatic castration-resistant prostate cancer in very elderly patients: challenges and solutions
par: Caffo O, et autres
Publié: (2016) -
PARP inhibitors and metastatic castration-resistant prostate cancer: uture directions and pitfalls
par: A. Franza, et autres
Publié: (2022)